Allergies News and Research

Latest Allergies News and Research

New study provides insight into developing therapeutics for airway disease

Researchers from Duke University Medical Center have identified how nanoparticles from diesel exhaust damage lung airway cells, a finding that could lead to new therapies for people susceptible to airway disease.

19 Jan 2011

Positive preliminary results from Soligenix's SGX202 in GARS model

Soligenix, Inc., a late-stage biopharmaceutical company, announced today promising preliminary results from a preclinical study of SGX202 in a canine gastrointestinal acute radiation syndrome model.

19 Jan 2011

Severe asthma in early childhood may lead to premature loss of lung function during adolescence: Study

Severe asthma in early childhood may lead to premature loss of lung function during adolescence and more serious disease during adulthood, researchers at Emory University School of Medicine report. Early identification and treatment of children with severe asthma is important to help stem asthma progression.

19 Jan 2011

Healthcare Information Xchange of New York completes implementation of InterSystems HealthShare HIE platform

InterSystems Corporation, the global leader in software for connected health care, today announced that the Healthcare Information Xchange of New York (HIXNY) has completed implementation of InterSystems HealthShare™ as its core health information exchange (HIE) platform.

18 Jan 2011

Teens living next to busy roadway face high risk of allergies and asthma: Study

An international team of lung experts has new evidence from a study in shantytowns near Lima, Peru, that teens living immediately next to a busy roadway have increased risk of allergies and asthma.

18 Jan 2011

Washington Post examines theories on climate change's potential impact on disease spread

The Washington Post examines the debate among scientists over the impact climate change might have on the spread of infectious diseases, and the potential for a rise in the number of tropical diseases in the U.S. The article describes how extreme weather conditions, such as flooding and drought - "thought to be linked to the warming of the oceans and to changes in the precipitation cycle" - can create ideal conditions for waterborne disease.

13 Jan 2011

Antibiotics for ear infection in kids better than watchful waiting: Study

Findings from two latest clinical trials reveal that a young child with ear infections recovers faster and more completely if doctors give antibiotics right away rather than waiting to see if the kid get better on his/her own. One of the studies was in the U.S. and one in Finland. Earlier it has been debated that for young children with middle ear infections or otitis media whether immediate antibiotic treatment was better than watchful waiting. Current treatment recommendations in the U.S., Canada, and Europe allow for a watch-and-wait approach to suspected middle ear infections in young children. Change is coming, predicts study leader Alejandro Hoberman, MD, of Children’s Hospital of Pittsburgh.

12 Jan 2011

Analysis of medical database reveals new diagnostic markers for allergic disorders

Researchers at the University of Gothenburg, Sweden, have developed new methods for analysing medical databases that can be used to identify diagnostic markers more quickly and to personalise medication for allergic disorders. They could also reduce the need for animal trials in clinical studies.

12 Jan 2011

Common rubber products can cause contact allergy: Study

Common rubber products can form isothiocyanates in contact with skin and cause contact allergy. This is the conclusion of research carried out at the University of Gothenburg. Isothiocyanates are a group of reactive substances that are potent contact allergens.

12 Jan 2011

Research could lead to new approaches to treat dementia

A researcher at the University of Pittsburgh School of Medicine, in collaboration with scientists from the National Institutes of Health, has discovered that the deadly plaques of Alzheimer's disease interact with certain cellular proteins to inhibit normal signals that maintain blood flow to the brain.

11 Jan 2011

DAPT shows positive outcomes following treatment with OrbusNeich's Genous Stent

Data from patients who are considered high-risk due to underlying clinical conditions and who cannot be treated with drug eluting stents and the accompanying requirement of long-term dual antiplatelet therapy showed positive safety and short- and long-term clinical outcomes following treatment with OrbusNeich's Genous Stent, according to a study published online in EuroIntervention.

11 Jan 2011

Plasminogen may serve as new target to treat prion diseases

Scientists at the University of Kentucky have discovered that plasminogen, a protein used by the body to break up blood clots, speeds up the progress of prion diseases such as mad cow disease.

11 Jan 2011

Potential single vaccine for permanent immunity to all influenza

The search for a universal flu vaccine has received a boost from a surprising source: the 2009 H1N1 pandemic flu strain.

10 Jan 2011

Choosing between EGFR therapeutic options in metastatic colorectal cancer

Colorectal cancer (CRC) is the third most common cancer in men and women in the USA, with a new diagnosis made every 3.5 minutes and an associated death every 9 minutes.

6 Jan 2011

Profectus BioSciences commences GENEVAX IL-12 phase 1 study for HIV

Profectus BioSciences, a leader in the development of therapeutic and preventive vaccines against infectious diseases and cancers, and the AIDS Clinical Trials Group announced today the initiation of a phase 1 study of Profectus' multi-antigen HIV plasmid DNA vaccine administered with various doses of GENEVAX™ interleukin-12 pDNA adjuvant and delivered using the electroporation based TriGrid™delivery system developed by Ichor Medical Systems.

6 Jan 2011

DBV Technologies secures $25.5 million in Series C financing round

DBV Technologies, an emerging biotechnology company, announced today that it has secured $25.5 million (€19,4 million) in a Series C financing round. The round was co-led by new investors InnoBio Fund (managed by CDC Entreprises within FSI France Investment program) and Lundbeckfond Ventures.

5 Jan 2011

Health and Safety Watch tracks over 500 food and product advisories and recalls in 2010

This year Health and Safety Watch tracked more than 500 advisories and recalls issued for food and products in Canada. The events included everything from the recent Quaker Canada cereal bar recall due to the possible presence of peanuts, to big ticket items such as GE dishwashers recalled due to possible fire hazards.

30 Dec 2010

Tips to avoid allergy and asthma triggers at the gym

A New Year's resolution to get in shape is good news for your health. But if you have allergies or asthma, the hidden triggers at the gym may be bad for your condition.

30 Dec 2010

Low levels of microbe-killing molecules improve survival rate of people with CGD

Investigators at the National Institutes of Health have observed that the survival rate of people with a rare immunodeficiency disease called chronic granulomatous disease is greatly improved when even very low levels of microbe-killing molecules are present.

30 Dec 2010

Vitamin D levels of newborns appear to predict their risk of respiratory infections

The vitamin D levels of newborn babies appear to predict their risk of respiratory infections during infancy and the occurrence of wheezing during early childhood, but not the risk of developing asthma. Results of a study in the January 2011 issue of Pediatrics support the theory that widespread vitamin D deficiency contributes to risk of infections.

27 Dec 2010